Search

Your search keyword '"Feltes, Rosa"' showing total 16 results
Start Over Author "Feltes, Rosa"
16 results on '"Feltes, Rosa"'

1. Multicenter Retrospective Study of Secukinumab Drug Survival in Psoriasis Patients in a Daily Practice Setting: A Long-Term Experience in Spain

Author

Daudén, Esteban, de Lima, Glauber Pacelli Gomes, Armesto, Susana, Herrera-Acosta, Enrique, Vidal, David, Villarasa, Eva, Rivera, Raquel, de la Cueva, Pablo, Martorell, Antonio, Ballesca, Ferran, Belinchón, Isabel, Carretero, Gregorio, Rodríguez, Lourdes, Romero-Maté, Alberto, Pujol-Montcusí, Josep, Salgado, Laura, Sahuquillo-Torralba, Antonio, Coto-Segura, Pablo, Baniandrés, Ofelia, Feltes, Rosa, Alsina, Mercé, and Llamas-Velasco, Mar

Published
2021
Full Text
View/download PDF

2. Ustekinumab is effective and safe in the long‐term treatment of erythrodermic psoriasis: Multicenter study in daily practice

Author

Plana, Clara, primary, Concha‐Garzón, Maria J., additional, Rocamora, Vicen C., additional, Baniandrés, Ofelia, additional, Feltes, Rosa, additional, López‐Estebaranz, Jose L., additional, Garcías‐Ladaria, Joan, additional, Carrascosa, Jose‐Manuel, additional, Vilarrasa, Eva, additional, Soria, Caridad, additional, Navajas, Belen, additional, Llamas‐Velasco, Mar, additional, and Dauden, Esteban, additional

Published
2024
Full Text
View/download PDF

3. Secukinumab is effective and safe in the long‐term treatment of plaque psoriasis in a daily practice setting: Multicenter study in 384 Spanish patients

Author

Chicharro, Pablo, primary, Llamas‐Velasco, Mar, additional, Armesto, Susana, additional, Herrera Acosta, Enrique, additional, Vidal, David, additional, Vilarrasa, Eva, additional, Rivera‐Diaz, Raquel, additional, De‐la‐Cueva, Pablo, additional, Martorell‐Calatayud, Antonio, additional, Ballescà, Ferran, additional, Belinchon, Isabel, additional, Carretero, Gregorio, additional, Rodriguez, Lourdes, additional, Romero‐Maté, Alberto, additional, Pujol‐Montcusí, Josep, additional, Salgado, Laura, additional, Sahuquillo‐Torralba, Antonio, additional, Coto‐Segura, Pablo, additional, Baniandrés Rodríguez, Ofelia, additional, Feltes, Rosa, additional, Riera‐Monroig, José, additional, and Dauden, Esteban, additional

Published
2022
Full Text
View/download PDF

4. Secukinumab is effective in the treatment of recalcitrant palmoplantar psoriasis and palmoplantar pustular psoriasis in a daily practice setting

Author

Reolid, Alejandra, primary, Armesto, Susana, additional, Sahuquillo-Torralba, Antonio, additional, Torres, Tiago, additional, Feltes, Rosa, additional, Vilarrasa, Eva, additional, Belinchón, Isabel, additional, Cueva, Pablo de la, additional, Rodríguez, Lourdes, additional, Romero-Maté, Alberto, additional, Vidal, David, additional, Coto-Segura, Pablo, additional, Herrera-Acosta, Enrique, additional, Riera-Monroig, Josep, additional, Salgado, Laura, additional, Llamas-Velasco, Mar, additional, and Daudén, Esteban, additional

Published
2022
Full Text
View/download PDF

5. Fast and sustained improvement of patient‐reported outcomes in psoriatic patients treated with secukinumab in a daily practice setting

Author

Chicharro, Pablo, primary, Llamas‐Velasco, Mar, additional, Armesto, Susana, additional, Herrera‐Acosta, Enrique, additional, Vidal, David, additional, Vilarrasa, Eva, additional, Rivera, Raquel, additional, De la Cueva, Pablo, additional, Martorell‐Calatayud, Antonio, additional, Ballescà, Ferrán, additional, Belinchón, Isabel, additional, Carretero, Gregorio, additional, Rodríguez, Lourdes, additional, Romero‐Maté, Alberto, additional, Pujol‐Montcusí, Josep, additional, Salgado, Laura, additional, Sahuquillo‐Torralba, Antonio, additional, Coto‐Segura, Pablo, additional, Baniandrés‐Rodríguez, Ofelia, additional, Feltes, Rosa, additional, Alsina, Mercè, additional, and Daudén, Esteban, additional

Published
2022
Full Text
View/download PDF

8. Cancer immunotherapy does not increase the risk of death by COVID-19 in melanoma patients

Author

Gonzalez-Cao, Maria, primary, Antonazas-Basa, Monica, additional, Puertolas, Teresa, additional, Munoz-Couselo, Eva, additional, Manzano, Jose Luis, additional, Carrera, Cristina, additional, Marquez-Rodas, Ivan, additional, Lopez-Criado, Pilar, additional, Rodriguez-Moreno, Juan Francisco, additional, Garcia-Castano, Almudena, additional, Martin-Liberal, Juan, additional, Rodriguez-Jimenez, Pedro, additional, Puig, Susana, additional, Cerezuela, Pablo, additional, Feito-Rodriguez, Marta, additional, Rubio-Viqueira, Belen, additional, Crespo, Guillermo, additional, Luna-Fra, Pablo, additional, Aguayo, Cristina, additional, Ayala de Miguel, Pablo, additional, Feltes, Rosa, additional, Valles, Lara, additional, Drozdowskyj, Ana, additional, Soria, Ainara, additional, Maldonado, Cayetana, additional, Fernandez-Morales, Luis, additional, Rosell, Rafael, additional, Provencio, Mariano, additional, and Berrocal, Alfonso, additional

Published
2020
Full Text
View/download PDF

14. Uso de pomada de tacrolimus al 0,1% durante un año en niños con vitiligo.

Author

Feltes, Rosa, Floristán, Uxúa, Sendagorta, Elena, Ramírez, Paloma, Diez-Sebastian, Jesús, and Laguna, Raúl De Lucas

Subjects
*VITILIGO, *JUVENILE diseases, *ETIOLOGY of diseases, *TACROLIMUS, *PHOTOTHERAPY, *HORMONE therapy, *ADRENOCORTICAL hormones, *DRUG side effects, *RETROSPECTIVE studies, *THERAPEUTICS
Abstract

Background: Vitiligo is a skin disorder with a predominant autoimmune etiology, characterized by depigmentation of skin and hair. In children, this condition becomes a serious esthetic problem, as well as a therapeutic challenge, due to frequent adverse reactions caused by standard treatments (phototherapy and corticosteroids). Methods: A retrospective study was carried out at the Pediatric Dermatological Unit of La Paz Hospital, with patients treated between 2002 and 2008. Response after one year of treatment with topical tacrolimus 0.1% ointment in 22 young patients (2 to 16 year-old) diagnosed of vitiligo, was assessed. Results: Some degree of repigmentation was observed in 81.8% of patients. A statistical analysis showed that significant response was observed in face, neck and extremities after 9 months of treatment, while in the trunk improvement occurred after 12 months. No related adverse reactions were observed during the treatment period. Conclusion: Tacrolimus ointment could be a good therapeutic option in pediatric patients affected with vitiligo. [ABSTRACT FROM AUTHOR]

Published
2011

15. [Erythematous-violaceous lesion on the leg of a researcher in contact with swine].

Author

Floristán U, Feltes RA, Gómez A, and Vidaurrázaga C

Subjects
Adult, Agricultural Workers' Diseases microbiology, Animals, Dermatitis, Occupational microbiology, Erysipeloid microbiology, Erysipeloid transmission, Humans, Leg, Male, Swine microbiology, Swine Erysipelas microbiology, Agricultural Workers' Diseases diagnosis, Animal Husbandry, Dermatitis, Occupational diagnosis, Erysipeloid diagnosis, Erysipelothrix isolation & purification, Research Personnel
Published
2009
Full Text
View/download PDF

16. Diffuse melanosis and ascites due to metastatic malignant melanoma.

Author

Sendagorta E, Pizarro A, Feito M, Mayor M, Ramírez P, Floristan U, and Feltes R

Subjects
Aged, Ascites etiology, Female, Humans, Melanoma complications, Melanosis etiology, Skin Neoplasms complications, Ascites diagnosis, Melanoma diagnosis, Melanoma secondary, Melanosis diagnosis, Skin Neoplasms diagnosis
Abstract

We present a female patient who developed mucosal and skin hyperpigmentation due to metastatic malignant melanoma. Diffuse cutaneous melanosis is a rare entity that complicates a small percentage of metastatic melanomas, confering a fatal prognosis. We discuss briefly the current evidence on pathogenesis of melanosis arising from metastatic melanoma.

Published
2008
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results